Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis
- PMID: 10025935
- DOI: 10.1002/1529-0131(199902)42:2<384::AID-ANR22>3.0.CO;2-X
Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis
Abstract
We describe a patient who presented with Wegener's granulomatosis associated with antineutrophil cytoplasmic antibodies (ANCA) directed against proteinase 3 (PR3) with a cytoplasmic immunofluorescence pattern (cANCA), whose ANCA type changed to antimyeloperoxidase antibodies with a perinuclear immunofluorescence pattern (pANCA) when treated with propylthiouracil, and changed back to anti-PR3 antibodies with cANCA after the medication was discontinued. The patient developed flares of vasculitis symptoms associated with rises in either type of ANCA. Tests for antimyeloperoxidase ANCA were repeatedly negative before the drug was started, strongly implicating the drug as the cause of the episode. This case demonstrates that patients with idiopathic ANCA-positive vasculitis may quickly develop a superimposed drug-associated ANCA-positive vasculitis. Iatrogenic vasculitis should be suspected when a patient with idiopathic vasculitis with one type of ANCA develops the other type of ANCA.
Comment in
-
Specificity of antineutrophil cytoplasmic antibody: comment on the article by Choi et al.Arthritis Rheum. 1999 Nov;42(11):2494-5. doi: 10.1002/1529-0131(199911)42:11<2494::AID-ANR34>3.0.CO;2-E. Arthritis Rheum. 1999. PMID: 10555049 No abstract available.
Similar articles
-
Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.Arthritis Res Ther. 2005;7(5):R1072-81. doi: 10.1186/ar1789. Epub 2005 Jul 13. Arthritis Res Ther. 2005. PMID: 16207324 Free PMC article.
-
Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.J Rheumatol. 2001 Jul;28(7):1584-90. J Rheumatol. 2001. PMID: 11469466
-
Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.Arthritis Rheum. 2001 Feb;44(2):463-8. doi: 10.1002/1529-0131(200102)44:2<463::AID-ANR65>3.0.CO;2-9. Arthritis Rheum. 2001. PMID: 11229478
-
Pathogenesis of PR3-ANCA associated vasculitis.J Autoimmun. 2008 Feb-Mar;30(1-2):29-36. doi: 10.1016/j.jaut.2007.11.005. Epub 2007 Dec 26. J Autoimmun. 2008. PMID: 18162369 Review.
-
Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies.Arthritis Rheum. 2000 Jan;43(1):226-31. doi: 10.1002/1529-0131(200001)43:1<226::AID-ANR27>3.0.CO;2-Q. Arthritis Rheum. 2000. PMID: 10643719 Review.
Cited by
-
Antineutrophil cytoplasmic antibody-positive vasculitis associated with propylthiouracil therapy.Clin Drug Investig. 2003;23(12):817-21. doi: 10.2165/00044011-200323120-00006. Clin Drug Investig. 2003. PMID: 17536895 No abstract available.
-
Clinical utility of testing for antineutrophil cytoplasmic antibodies.Clin Diagn Lab Immunol. 1999 Sep;6(5):645-51. doi: 10.1128/CDLI.6.5.645-651.1999. Clin Diagn Lab Immunol. 1999. PMID: 10473510 Free PMC article. Review. No abstract available.
-
Drug-induced vasculitis.Curr Rheumatol Rep. 2002 Feb;4(1):55-9. doi: 10.1007/s11926-002-0024-y. Curr Rheumatol Rep. 2002. PMID: 11798983 Review.
-
Laboratory testing in the evaluation and diagnosis of vasculitis.Curr Rheumatol Rep. 2000 Oct;2(5):417-22. doi: 10.1007/s11926-000-0042-6. Curr Rheumatol Rep. 2000. PMID: 11123092 Review.
-
A fatal case of propylthiouracil-induced ANCA-positive vasculitis.MedGenMed. 2006 Oct 12;8(4):10. MedGenMed. 2006. PMID: 17415292 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical